Comparing Ketorolac and Morphine for Pain Relief in Children with Appendicitis
Official title: Intravenous Ketorolac Vs. Morphine In Children Presenting With Acute Abdominal Pain And/or Suspected Appendicitis: A Multi-centre Non-Inferiority Randomized Controlled Trial
Run by University of Calgary · NCT06160778 · Data updated 2026-11-12
This study is testing if ketorolac can help relieve pain just as well as morphine in children aged 6-17 who might have appendicitis.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 6 Years to 17 Years |
| Sex | All |
| Enrollment | 495 (estimated) |
| Sponsor | University of Calgary Academic / other |
| Locations | 1 site (Calgary, Alberta) |
| Status | Recruiting |
| Started | May 27, 2024 |
| Main results expected | January 2029 |
| Study ends | December 2029 |
| Registry record updated | June 24, 2024 |
| Trial ID | NCT06160778 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 6-17 years experiencing moderate to severe abdominal pain for up to five days, suspected of having appendicitis.
✕Probably not a fit
Patients who are hemodynamically unstable or require immediate resuscitation will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of intravenous ketorolac compared to morphine in reducing pain in children aged 6-17 years with suspected appendicitis. The study will involve a randomized quadruple-blind design across four pediatric emergency departments in Canada, where eligible participants will receive either ketorolac or a placebo while their pain levels are monitored. The primary goal is to determine if ketorolac is as effective as morphine in managing pain, while also assessing the safety profile of both medications. This research addresses the need for safer pain management alternatives amid the ongoing opioid crisis.
Why it matters
Potential benefit: If successful, this study could provide a safer, effective alternative to opioids for managing acute abdominal pain in children.
How similar studies have gone: Previous studies have shown promising results for ketorolac in adult populations, but this specific approach in children is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 6 to 17 years 2. Abdominal pain ≤5 days duration 3. Acute abdominal pain that is being investigated (suspected) by the clinical team for appendicitis 4. Patient with IV cannula in situ or ordered 5. Currently experiencing moderate to severe abdominal pain at rest or with movement: self-reported pain score ≥5 using the verbal Numerical Rating Scale Exclusion Criteria: 1. Previous enrollment in the trial 2. NSAID use within 3 hours and/or opioid use within 1 to 2 hours (1 hour post-IV or intra-nasal fentanyl and 2 hours post IV morphine). 3. Children who need immediate resuscitation, are hemodynamically unstable as deemed by the clinical team or have a Canadian Triage Assessment Score of 1 4. Significant caregiver and/or child cognitive impairment precluding the ability to complete study questions. 5. Chronic pain requiring daily analgesic use: confounding as response to analgesics maybe altered. 6. History of severe undiagnosed gastrointestinal bleeding requiring medical intervention, peptic or duodenal ulcer disease or inflammatory bowel disease, coagulation disorders, prior cerebrovascular bleeding, known arterio-vascular malformations. History of minor gastrointestinal bleeding from conditions such as resolved fissures, polyps or allergic colitis will not exclude patients from participating. 7. History of chronic and active interstitial kidney disease 8. History of chronic and active hepatocellular disease: ketorolac is metabolized by the liver. 9. Known or suspected pregnancy at the time of enrollment or breastfeeding females 10. Known hypersensitivity to NSAIDs or opioids. 11. Absence of a parent/guardian for children who are \<16 years of age if they are not a mature minor. 12. Inability to obtain consent due to a language barrier and the absence of language translator in person or by a phone translation service available in the ED.
Where it's running
-
Alberta Children's Hospital Emergency Department
Calgary, Alberta, Canada Recruiting
Study contacts
- Principal investigator: Mohamed Eltorki, MBChB — University of Calgary
- Study coordinator: Mohamed M Eltorki, MBChB, MSc
- Email: mmeltork@ucalgary.ca
- Phone: +1403-955-7723
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gut health follow-along with Peachbiotic in adults
This single-arm study tests whether Peachbiotic taken daily for 12 weeks helps adults with gut symptoms feel better.
-
Prebiotic and Probiotic Combo for Constipation Symptoms
This study tests whether adding 1-kestose to a probiotic (BBH112) helps adults with constipation-related symptoms see more relief and better quality of life.
-
Predictors of severe pain within 24 hours after cesarean delivery with spinal anesthesia
This study will look at which pre-, intra-, and post-operative factors are linked to severe pain in the first 24 hours after an elective cesarean done with spinal anesthesia.
-
Transverse vs Longitudinal Serratus Anterior Plane Block for Breast Surgery
This trial tests whether a longitudinal ultrasound view for serratus anterior plane block provides better pain relief after breast surgery than the standard transverse view.
-
Combined PECS II and PIP blocks vs TPVB for post-mastectomy pain relief
This trial tests whether a combination of PECS II and superficial PIP blocks can provide better or similar pain relief after mastectomy compared with the standard thoracic paravertebral block.
-
Two Different Therapeutic Distractions Used During Blood Draw for Children Aged 5–7
This study tests whether two distraction methods during blood sampling can reduce pain, fear, and anxiety in 5–7 year-olds compared with routine care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.